Schumacher U - Search Results

1

Opposing prognostic relevance of junction plakoglobin in distinct prostate cancer patient subsets.

Spethmann T, Böckelmann LC, Labitzky V, Ahlers AK, Schröder-Schwarz J, Bonk S, Simon R, Sauter G, Huland H, Kypta R, Schumacher U, Lange T. Spethmann T, et al. Among authors: schumacher u. Mol Oncol. 2021 Jul;15(7):1956-1969. doi: 10.1002/1878-0261.12922. Epub 2021 Feb 17. Mol Oncol. 2021. PMID: 33533127 Free PMC article.

2

Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions.

Kluth M, Hesse J, Heinl A, Krohn A, Steurer S, Sirma H, Simon R, Mayer PS, Schumacher U, Grupp K, Izbicki JR, Pantel K, Dikomey E, Korbel JO, Plass C, Sauter G, Schlomm T, Minner S. Kluth M, et al. Among authors: schumacher u. Mod Pathol. 2013 Jul;26(7):975-83. doi: 10.1038/modpathol.2012.236. Epub 2013 Feb 1. Mod Pathol. 2013. PMID: 23370768 Free article.

3

Prognostic relevance of ubiquitin C-terminal hydrolase L1 (UCH-L1) mRNA and protein expression in breast cancer patients.

Schröder C, Milde-Langosch K, Gebauer F, Schmid K, Mueller V, Wirtz RM, Meyer-Schwesinger C, Schlüter H, Sauter G, Schumacher U. Schröder C, et al. Among authors: schumacher u. J Cancer Res Clin Oncol. 2013 Oct;139(10):1745-55. doi: 10.1007/s00432-013-1496-z. Epub 2013 Aug 31. J Cancer Res Clin Oncol. 2013. PMID: 23996067

4

Aberrant presentation of HPA-reactive carbohydrates implies Selectin-independent metastasis formation in human prostate cancer.

Lange T, Kupfernagel M, Wicklein D, Gebauer F, Maar H, Brügge K, Müller I, Simon R, Schlomm T, Sauter G, Schumacher U. Lange T, et al. Among authors: schumacher u. Clin Cancer Res. 2014 Apr 1;20(7):1791-802. doi: 10.1158/1078-0432.CCR-13-2308. Epub 2014 Feb 13. Clin Cancer Res. 2014. PMID: 24526735

5

Development and Characterization of a Spontaneously Metastatic Patient-Derived Xenograft Model of Human Prostate Cancer.

Lange T, Oh-Hohenhorst SJ, Joosse SA, Pantel K, Hahn O, Gosau T, Dyshlovoy SA, Wellbrock J, Feldhaus S, Maar H, Gehrcke R, Kluth M, Simon R, Schlomm T, Huland H, Schumacher U. Lange T, et al. Among authors: schumacher u. Sci Rep. 2018 Dec 3;8(1):17535. doi: 10.1038/s41598-018-35695-8. Sci Rep. 2018. PMID: 30510249 Free PMC article.

6

Xenograft-derived mRNA/miR and protein interaction networks of systemic dissemination in human prostate cancer.

Lange T, Samatov TR, Galatenko VV, Steffen P, von Kriegstein H, Spethmann T, Wicklein D, Maar H, Kupfernagel K, Labitzky V, Hanika S, Starzonek S, Ahlers AK, Riecken K, Simon R, Polonski A, Sauter G, Schlomm T, Huland H, Johnsen SA, Schlüter H, Tonevitsky AG, Schumacher U. Lange T, et al. Among authors: schumacher u. Eur J Cancer. 2020 Sep;137:93-107. doi: 10.1016/j.ejca.2020.06.025. Epub 2020 Aug 1. Eur J Cancer. 2020. PMID: 32750503 Free article.

7

Thioredoxin Interacting Protein (TXNIP) Is Differentially Expressed in Human Tumor Samples but Is Absent in Human Tumor Cell Line Xenografts: Implications for Its Use as an Immunosurveillance Marker.

Schröder J, Schumacher U, Böckelmann LC. Schröder J, et al. Among authors: schumacher u. Cancers (Basel). 2020 Oct 18;12(10):3028. doi: 10.3390/cancers12103028. Cancers (Basel). 2020. PMID: 33081035 Free PMC article.

8

CHD1 loss negatively influences metastasis-free survival in R0-resected prostate cancer patients and promotes spontaneous metastasis in vivo.

Oh-Hohenhorst SJ, Tilki D, Ahlers AK, Suling A, Hahn O, Tennstedt P, Matuszcak C, Maar H, Labitzky V, Hanika S, Starzonek S, Baumgart S, Johnsen SA, Kluth M, Sirma H, Simon R, Sauter G, Huland H, Schumacher U, Lange T. Oh-Hohenhorst SJ, et al. Among authors: schumacher u. Cancer Gene Ther. 2022 Jan;29(1):49-61. doi: 10.1038/s41417-020-00288-z. Epub 2021 Jan 7. Cancer Gene Ther. 2022. PMID: 33414516 Free PMC article.

9

Analyzing tyrosine kinase activity in head and neck cancer by functional kinomics: Identification of hyperactivated Src family kinases as prognostic markers and potential targets.

Bußmann L, Hoffer K, von Bargen CM, Droste C, Lange T, Kemmling J, Schröder-Schwarz J, Vu AT, Akingunsade L, Nollau P, Rangarajan S, de Wijn R, Oetting A, Müller C, Böckelmann LC, Zech HB, Berger JC, Möckelmann N, Busch CJ, Böttcher A, Gatzemeier F, Klinghammer K, Simnica D, Binder M, Struve N, Rieckmann T, Schumacher U, Clauditz TS, Betz CS, Petersen C, Rothkamm K, Münscher A, Kriegs M. Bußmann L, et al. Among authors: schumacher u. Int J Cancer. 2021 Sep 1;149(5):1166-1180. doi: 10.1002/ijc.33606. Epub 2021 May 7. Int J Cancer. 2021. PMID: 33890294

10

Molecular characteristics and tumorigenicity of ascites-derived tumor cells: mitochondrial oxidative phosphorylation as a novel therapy target in ovarian cancer.

Ding Y, Labitzky V, Legler K, Qi M, Schumacher U, Schmalfeldt B, Stürken C, Oliveira-Ferrer L. Ding Y, et al. Among authors: schumacher u. Mol Oncol. 2021 Dec;15(12):3578-3595. doi: 10.1002/1878-0261.13028. Epub 2021 Jun 18. Mol Oncol. 2021. PMID: 34060699 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

574 results

Search Page

Filters